ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Urticaria Drug Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-38Q7570
Home | Market Reports | Health| Health Conditions| Skin Conditions
Global Urticaria Drug Market Insights Forecast to 2028
BUY CHAPTERS

Global Urticaria Drug Market Research Report 2025

Code: QYRE-Auto-38Q7570
Report
July 2025
Pages:83
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Johnson And Johnson Services
Amneal Pharmaceuticals
Pfizer Inc
Taro Pharmaceutical Industries Novartis AG
Akorn
Teva Pharmaceutical Industries
Genentech Inc
Xolair

Urticaria Drug Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Urticaria Drug Market

Urticaria Drug Market

The global market for Urticaria Drug was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Urticaria is commonly known as rubella. It is a localized edema response due to dilation of the skin and mucosal small blood vessels and increased permeability. It usually subsides within 2 to 24 hours, but new rashes occur repeatedly. The course of the disease is delayed for several days to several months. More common in clinically.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Urticaria Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Urticaria Drug.
The Urticaria Drug market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Urticaria Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Urticaria Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Urticaria Drug Market Report

Report Metric Details
Report Name Urticaria Drug Market
CAGR 5%
Segment by Type
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Johnson and Johnson Services, Amneal Pharmaceuticals, Pfizer, Taro Pharmaceutical Industries Novartis AG, Akorn, Teva Pharmaceutical Industries, Genentech, Xolair
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Urticaria Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Urticaria Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Urticaria Drug Market report?

Ans: The main players in the Urticaria Drug Market are Johnson and Johnson Services, Amneal Pharmaceuticals, Pfizer, Taro Pharmaceutical Industries Novartis AG, Akorn, Teva Pharmaceutical Industries, Genentech, Xolair

What are the Application segmentation covered in the Urticaria Drug Market report?

Ans: The Applications covered in the Urticaria Drug Market report are Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others

What are the Type segmentation covered in the Urticaria Drug Market report?

Ans: The Types covered in the Urticaria Drug Market report are Acute Urticaria, Chronic Urticaria

Recommended Reports

Allergy Drugs

Skin Disease Drugs

Respiratory and Immune

1 Urticaria Drug Market Overview
1.1 Product Definition
1.2 Urticaria Drug by Type
1.2.1 Global Urticaria Drug Market Value Comparison by Type (2024 VS 2031)
1.2.2 Acute Urticaria
1.2.3 Chronic Urticaria
1.3 Urticaria Drug by Application
1.3.1 Global Urticaria Drug Market Value by Application (2024 VS 2031)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.3.5 Others
1.4 Global Urticaria Drug Market Size Estimates and Forecasts
1.4.1 Global Urticaria Drug Revenue 2020-2031
1.4.2 Global Urticaria Drug Sales 2020-2031
1.4.3 Global Urticaria Drug Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Urticaria Drug Market Competition by Manufacturers
2.1 Global Urticaria Drug Sales Market Share by Manufacturers (2020-2025)
2.2 Global Urticaria Drug Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Urticaria Drug Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Urticaria Drug, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Urticaria Drug, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Urticaria Drug, Product Type & Application
2.7 Global Key Manufacturers of Urticaria Drug, Date of Enter into This Industry
2.8 Global Urticaria Drug Market Competitive Situation and Trends
2.8.1 Global Urticaria Drug Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Urticaria Drug Players Market Share by Revenue
2.8.3 Global Urticaria Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Urticaria Drug Market Scenario by Region
3.1 Global Urticaria Drug Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Urticaria Drug Sales by Region: 2020-2031
3.2.1 Global Urticaria Drug Sales by Region: 2020-2025
3.2.2 Global Urticaria Drug Sales by Region: 2026-2031
3.3 Global Urticaria Drug Revenue by Region: 2020-2031
3.3.1 Global Urticaria Drug Revenue by Region: 2020-2025
3.3.2 Global Urticaria Drug Revenue by Region: 2026-2031
3.4 North America Urticaria Drug Market Facts & Figures by Country
3.4.1 North America Urticaria Drug Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Urticaria Drug Sales by Country (2020-2031)
3.4.3 North America Urticaria Drug Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Urticaria Drug Market Facts & Figures by Country
3.5.1 Europe Urticaria Drug Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Urticaria Drug Sales by Country (2020-2031)
3.5.3 Europe Urticaria Drug Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Urticaria Drug Market Facts & Figures by Region
3.6.1 Asia Pacific Urticaria Drug Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Urticaria Drug Sales by Region (2020-2031)
3.6.3 Asia Pacific Urticaria Drug Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Urticaria Drug Market Facts & Figures by Country
3.7.1 Latin America Urticaria Drug Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Urticaria Drug Sales by Country (2020-2031)
3.7.3 Latin America Urticaria Drug Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Urticaria Drug Market Facts & Figures by Country
3.8.1 Middle East and Africa Urticaria Drug Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Urticaria Drug Sales by Country (2020-2031)
3.8.3 Middle East and Africa Urticaria Drug Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Urticaria Drug Sales by Type (2020-2031)
4.1.1 Global Urticaria Drug Sales by Type (2020-2025)
4.1.2 Global Urticaria Drug Sales by Type (2026-2031)
4.1.3 Global Urticaria Drug Sales Market Share by Type (2020-2031)
4.2 Global Urticaria Drug Revenue by Type (2020-2031)
4.2.1 Global Urticaria Drug Revenue by Type (2020-2025)
4.2.2 Global Urticaria Drug Revenue by Type (2026-2031)
4.2.3 Global Urticaria Drug Revenue Market Share by Type (2020-2031)
4.3 Global Urticaria Drug Price by Type (2020-2031)
5 Segment by Application
5.1 Global Urticaria Drug Sales by Application (2020-2031)
5.1.1 Global Urticaria Drug Sales by Application (2020-2025)
5.1.2 Global Urticaria Drug Sales by Application (2026-2031)
5.1.3 Global Urticaria Drug Sales Market Share by Application (2020-2031)
5.2 Global Urticaria Drug Revenue by Application (2020-2031)
5.2.1 Global Urticaria Drug Revenue by Application (2020-2025)
5.2.2 Global Urticaria Drug Revenue by Application (2026-2031)
5.2.3 Global Urticaria Drug Revenue Market Share by Application (2020-2031)
5.3 Global Urticaria Drug Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Johnson and Johnson Services
6.1.1 Johnson and Johnson Services Company Information
6.1.2 Johnson and Johnson Services Description and Business Overview
6.1.3 Johnson and Johnson Services Urticaria Drug Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Johnson and Johnson Services Urticaria Drug Product Portfolio
6.1.5 Johnson and Johnson Services Recent Developments/Updates
6.2 Amneal Pharmaceuticals
6.2.1 Amneal Pharmaceuticals Company Information
6.2.2 Amneal Pharmaceuticals Description and Business Overview
6.2.3 Amneal Pharmaceuticals Urticaria Drug Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Amneal Pharmaceuticals Urticaria Drug Product Portfolio
6.2.5 Amneal Pharmaceuticals Recent Developments/Updates
6.3 Pfizer
6.3.1 Pfizer Company Information
6.3.2 Pfizer Description and Business Overview
6.3.3 Pfizer Urticaria Drug Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Pfizer Urticaria Drug Product Portfolio
6.3.5 Pfizer Recent Developments/Updates
6.4 Taro Pharmaceutical Industries Novartis AG
6.4.1 Taro Pharmaceutical Industries Novartis AG Company Information
6.4.2 Taro Pharmaceutical Industries Novartis AG Description and Business Overview
6.4.3 Taro Pharmaceutical Industries Novartis AG Urticaria Drug Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Taro Pharmaceutical Industries Novartis AG Urticaria Drug Product Portfolio
6.4.5 Taro Pharmaceutical Industries Novartis AG Recent Developments/Updates
6.5 Akorn
6.5.1 Akorn Company Information
6.5.2 Akorn Description and Business Overview
6.5.3 Akorn Urticaria Drug Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Akorn Urticaria Drug Product Portfolio
6.5.5 Akorn Recent Developments/Updates
6.6 Teva Pharmaceutical Industries
6.6.1 Teva Pharmaceutical Industries Company Information
6.6.2 Teva Pharmaceutical Industries Description and Business Overview
6.6.3 Teva Pharmaceutical Industries Urticaria Drug Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Teva Pharmaceutical Industries Urticaria Drug Product Portfolio
6.6.5 Teva Pharmaceutical Industries Recent Developments/Updates
6.7 Genentech
6.7.1 Genentech Company Information
6.7.2 Genentech Description and Business Overview
6.7.3 Genentech Urticaria Drug Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Genentech Urticaria Drug Product Portfolio
6.7.5 Genentech Recent Developments/Updates
6.8 Xolair
6.8.1 Xolair Company Information
6.8.2 Xolair Description and Business Overview
6.8.3 Xolair Urticaria Drug Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Xolair Urticaria Drug Product Portfolio
6.8.5 Xolair Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Urticaria Drug Industry Chain Analysis
7.2 Urticaria Drug Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Urticaria Drug Production Mode & Process Analysis
7.4 Urticaria Drug Sales and Marketing
7.4.1 Urticaria Drug Sales Channels
7.4.2 Urticaria Drug Distributors
7.5 Urticaria Drug Customer Analysis
8 Urticaria Drug Market Dynamics
8.1 Urticaria Drug Industry Trends
8.2 Urticaria Drug Market Drivers
8.3 Urticaria Drug Market Challenges
8.4 Urticaria Drug Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Johnson And Johnson Services
Amneal Pharmaceuticals
Pfizer Inc
Taro Pharmaceutical Industries Novartis AG
Akorn
Teva Pharmaceutical Industries
Genentech Inc
Xolair
List of Tables
 Table 1. Global Urticaria Drug Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Urticaria Drug Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Urticaria Drug Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Urticaria Drug Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Urticaria Drug Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Urticaria Drug Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Urticaria Drug Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Urticaria Drug Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Urticaria Drug, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Urticaria Drug, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Urticaria Drug, Product Type & Application
 Table 12. Global Key Manufacturers of Urticaria Drug, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Urticaria Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Urticaria Drug as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Urticaria Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Urticaria Drug Sales by Region (2020-2025) & (K Units)
 Table 18. Global Urticaria Drug Sales Market Share by Region (2020-2025)
 Table 19. Global Urticaria Drug Sales by Region (2026-2031) & (K Units)
 Table 20. Global Urticaria Drug Sales Market Share by Region (2026-2031)
 Table 21. Global Urticaria Drug Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Urticaria Drug Revenue Market Share by Region (2020-2025)
 Table 23. Global Urticaria Drug Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Urticaria Drug Revenue Market Share by Region (2026-2031)
 Table 25. North America Urticaria Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Urticaria Drug Sales by Country (2020-2025) & (K Units)
 Table 27. North America Urticaria Drug Sales by Country (2026-2031) & (K Units)
 Table 28. North America Urticaria Drug Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Urticaria Drug Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Urticaria Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Urticaria Drug Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Urticaria Drug Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Urticaria Drug Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Urticaria Drug Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Urticaria Drug Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Urticaria Drug Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Urticaria Drug Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Urticaria Drug Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Urticaria Drug Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Urticaria Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Urticaria Drug Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Urticaria Drug Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Urticaria Drug Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Urticaria Drug Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Urticaria Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Urticaria Drug Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Urticaria Drug Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Urticaria Drug Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Urticaria Drug Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Urticaria Drug Sales (K Units) by Type (2020-2025)
 Table 51. Global Urticaria Drug Sales (K Units) by Type (2026-2031)
 Table 52. Global Urticaria Drug Sales Market Share by Type (2020-2025)
 Table 53. Global Urticaria Drug Sales Market Share by Type (2026-2031)
 Table 54. Global Urticaria Drug Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Urticaria Drug Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Urticaria Drug Revenue Market Share by Type (2020-2025)
 Table 57. Global Urticaria Drug Revenue Market Share by Type (2026-2031)
 Table 58. Global Urticaria Drug Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Urticaria Drug Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Urticaria Drug Sales (K Units) by Application (2020-2025)
 Table 61. Global Urticaria Drug Sales (K Units) by Application (2026-2031)
 Table 62. Global Urticaria Drug Sales Market Share by Application (2020-2025)
 Table 63. Global Urticaria Drug Sales Market Share by Application (2026-2031)
 Table 64. Global Urticaria Drug Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Urticaria Drug Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Urticaria Drug Revenue Market Share by Application (2020-2025)
 Table 67. Global Urticaria Drug Revenue Market Share by Application (2026-2031)
 Table 68. Global Urticaria Drug Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Urticaria Drug Price (US$/Unit) by Application (2026-2031)
 Table 70. Johnson and Johnson Services Company Information
 Table 71. Johnson and Johnson Services Description and Business Overview
 Table 72. Johnson and Johnson Services Urticaria Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Johnson and Johnson Services Urticaria Drug Product
 Table 74. Johnson and Johnson Services Recent Developments/Updates
 Table 75. Amneal Pharmaceuticals Company Information
 Table 76. Amneal Pharmaceuticals Description and Business Overview
 Table 77. Amneal Pharmaceuticals Urticaria Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Amneal Pharmaceuticals Urticaria Drug Product
 Table 79. Amneal Pharmaceuticals Recent Developments/Updates
 Table 80. Pfizer Company Information
 Table 81. Pfizer Description and Business Overview
 Table 82. Pfizer Urticaria Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Pfizer Urticaria Drug Product
 Table 84. Pfizer Recent Developments/Updates
 Table 85. Taro Pharmaceutical Industries Novartis AG Company Information
 Table 86. Taro Pharmaceutical Industries Novartis AG Description and Business Overview
 Table 87. Taro Pharmaceutical Industries Novartis AG Urticaria Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Taro Pharmaceutical Industries Novartis AG Urticaria Drug Product
 Table 89. Taro Pharmaceutical Industries Novartis AG Recent Developments/Updates
 Table 90. Akorn Company Information
 Table 91. Akorn Description and Business Overview
 Table 92. Akorn Urticaria Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Akorn Urticaria Drug Product
 Table 94. Akorn Recent Developments/Updates
 Table 95. Teva Pharmaceutical Industries Company Information
 Table 96. Teva Pharmaceutical Industries Description and Business Overview
 Table 97. Teva Pharmaceutical Industries Urticaria Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Teva Pharmaceutical Industries Urticaria Drug Product
 Table 99. Teva Pharmaceutical Industries Recent Developments/Updates
 Table 100. Genentech Company Information
 Table 101. Genentech Description and Business Overview
 Table 102. Genentech Urticaria Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Genentech Urticaria Drug Product
 Table 104. Genentech Recent Developments/Updates
 Table 105. Xolair Company Information
 Table 106. Xolair Description and Business Overview
 Table 107. Xolair Urticaria Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Xolair Urticaria Drug Product
 Table 109. Xolair Recent Developments/Updates
 Table 110. Key Raw Materials Lists
 Table 111. Raw Materials Key Suppliers Lists
 Table 112. Urticaria Drug Distributors List
 Table 113. Urticaria Drug Customers List
 Table 114. Urticaria Drug Market Trends
 Table 115. Urticaria Drug Market Drivers
 Table 116. Urticaria Drug Market Challenges
 Table 117. Urticaria Drug Market Restraints
 Table 118. Research Programs/Design for This Report
 Table 119. Key Data Information from Secondary Sources
 Table 120. Key Data Information from Primary Sources
 Table 121. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Urticaria Drug
 Figure 2. Global Urticaria Drug Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Urticaria Drug Market Share by Type: 2024 & 2031
 Figure 4. Acute Urticaria Product Picture
 Figure 5. Chronic Urticaria Product Picture
 Figure 6. Global Urticaria Drug Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Urticaria Drug Market Share by Application: 2024 & 2031
 Figure 8. Hospital Pharmacies
 Figure 9. Retail Pharmacies
 Figure 10. Online Pharmacies
 Figure 11. Others
 Figure 12. Global Urticaria Drug Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Urticaria Drug Market Size (2020-2031) & (US$ Million)
 Figure 14. Global Urticaria Drug Sales (2020-2031) & (K Units)
 Figure 15. Global Urticaria Drug Average Price (US$/Unit) & (2020-2031)
 Figure 16. Urticaria Drug Report Years Considered
 Figure 17. Urticaria Drug Sales Share by Manufacturers in 2024
 Figure 18. Global Urticaria Drug Revenue Share by Manufacturers in 2024
 Figure 19. Global 5 and 10 Largest Urticaria Drug Players: Market Share by Revenue in Urticaria Drug in 2024
 Figure 20. Urticaria Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 21. Global Urticaria Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 22. North America Urticaria Drug Sales Market Share by Country (2020-2031)
 Figure 23. North America Urticaria Drug Revenue Market Share by Country (2020-2031)
 Figure 24. United States Urticaria Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Canada Urticaria Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Europe Urticaria Drug Sales Market Share by Country (2020-2031)
 Figure 27. Europe Urticaria Drug Revenue Market Share by Country (2020-2031)
 Figure 28. Germany Urticaria Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. France Urticaria Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. U.K. Urticaria Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Italy Urticaria Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Russia Urticaria Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Asia Pacific Urticaria Drug Sales Market Share by Region (2020-2031)
 Figure 34. Asia Pacific Urticaria Drug Revenue Market Share by Region (2020-2031)
 Figure 35. China Urticaria Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Japan Urticaria Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. South Korea Urticaria Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. India Urticaria Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Australia Urticaria Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. China Taiwan Urticaria Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Indonesia Urticaria Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Thailand Urticaria Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Malaysia Urticaria Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Latin America Urticaria Drug Sales Market Share by Country (2020-2031)
 Figure 45. Latin America Urticaria Drug Revenue Market Share by Country (2020-2031)
 Figure 46. Mexico Urticaria Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Brazil Urticaria Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Argentina Urticaria Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Middle East and Africa Urticaria Drug Sales Market Share by Country (2020-2031)
 Figure 50. Middle East and Africa Urticaria Drug Revenue Market Share by Country (2020-2031)
 Figure 51. Turkey Urticaria Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Saudi Arabia Urticaria Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. UAE Urticaria Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Global Sales Market Share of Urticaria Drug by Type (2020-2031)
 Figure 55. Global Revenue Market Share of Urticaria Drug by Type (2020-2031)
 Figure 56. Global Urticaria Drug Price (US$/Unit) by Type (2020-2031)
 Figure 57. Global Sales Market Share of Urticaria Drug by Application (2020-2031)
 Figure 58. Global Revenue Market Share of Urticaria Drug by Application (2020-2031)
 Figure 59. Global Urticaria Drug Price (US$/Unit) by Application (2020-2031)
 Figure 60. Urticaria Drug Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Leap India

SIMILAR REPORTS

Global Papular Urticaria Drug Market Research Report 2024
Chronic Spontaneous Urticaria Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Allergic Conjunctivitis Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Hay Fever Drug Market Research Report 2025
Global Chronic Idiopathic Urticaria Treatment Market Research Report 2024
Hay Fever and Allergic Rhinitis Antihistamines Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Mast Cell Tumor Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Dermatitis Drugs Market Research Report 2024
Global Allergy Medicine Market Research Report 2024
Mugwort Pollen and Allergies Therapeutics Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Antiallergics Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Antihistamine Medications Market Research Report 2025
Hay Fever and Allergic Rhinitis Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Generic Allergy Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Birch Pollen Allergy Drug Market Research Report 2024
Global Chronic Urticaria Or Hives Drug Market Research Report 2025
Allergic Rhinitis Medication Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Rosacea Medications Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Birch Pollen and Allergies Therapeutics Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Dermatitis Herpetiformis Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Chronic Idiopathic Urticaria Treatment Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-38H16391
Tue Sep 23 00:00:00 UTC 2025

Add to Cart

Global Fungal Skin Disease Diagnostic Equipment Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-17T16810
Mon Sep 22 00:00:00 UTC 2025

Add to Cart

Global UVB Vitiligo Phototherapy Device Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-24Z16496
Mon Sep 22 00:00:00 UTC 2025

Add to Cart

Global Vitiligo Phototherapy Device Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-15I16746
Mon Sep 22 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions